This research study is being done to find out if giving zoledronic acid before the cancer spreads to the bone is better or worse than standard treatment. The study will also compare the effects (good and bad) of early treatment with zoledronic acid compared to standard treatment. In this study Group A will receive zoledronic acid and Group B will receive placebo (salt and water). The placebo contains no medication and is used to compare the effects of early treatment with zoledronic acid to no early treatment with zoledronic acid in a fair way. It is used so that neither you nor your doctor will know what you are receiving.
Condition | Metastatic Cancer, Prostate Cancer |
---|---|
Treatment | Placebo, Zoledronic Acid |
Clinical Study Identifier | NCT00698308 |
Sponsor | University of Medicine and Dentistry New Jersey |
Last Modified on | 7 November 2020 |
,
You have contacted , on
Your message has been sent to the study team at ,
You are contacting
Primary Contact
Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.
Learn moreIf you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.
Learn moreComplete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.
Learn moreEvery year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteer
Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!
No annotations made yet
Congrats! You have your own personal workspace now.